What Researchers Did
Researchers conducted a systematic review of 48 published papers to evaluate different treatments for chronic diffuse sclerosing osteomyelitis of the mandible.
What They Found
Out of 48 included papers, surgical treatment showed a low success rate and higher morbidity. Conservative treatment and bisphosphonates appeared to be the most promising therapeutic options for chronic diffuse sclerosing osteomyelitis of the mandible.
What This Means for Canadian Patients
Canadian patients with chronic diffuse sclerosing osteomyelitis of the mandible might benefit from discussing conservative treatment or bisphosphonate options with their healthcare providers. This could potentially lead to better outcomes and fewer complications compared to surgical interventions.
Canadian Relevance
This systematic review did not include any specific Canadian data or studies.
Study Limitations
The high risk of bias across the included studies prevented the researchers from drawing firm conclusions about treatment efficacy.